Insmed (NASDAQ:INSM) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.04) by 16.35 percent. This is a 27.37 percent decrease over losses of $(0.95) per share from the same period last year. The company reported quarterly sales of $59.30 million which missed the analyst consensus estimate of $62.28 million by 4.78 percent. This is a 5.66 percent increase over sales of $56.12 million the same period last year.
Insmed Q4 EPS $(1.21) Misses $(1.04) Estimate, Sales $59.30M Miss $62.28M Estimate
Insmed (NASDAQ:INSM) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.04) by 16.35 percent. This is a 27.37 percent decrease over losses of $(0.95) per share from the same
